GRUNENTHAL GMBH et al v. ACTAVIS LABORATORIES UT, INC. > Summary
Court Case Number 2:14-cv-04617
Filing Date Jul 23, 2014
Court New Jersey District Court
Status Unknown
Defendant
Plaintiff Attorneys
7Grunenthal
Attorney Name: John F. Brenner
Troutman Pepper Locke LLP
Grunenthal
Attorney Name: Melissa A. Chuderewicz
Troutman Pepper Locke LLP
Grunenthal
Attorney Name: Ronni E. Fuchs
Troutman Pepper Locke LLP
JANSSEN PHARMACEUTICALS (Johnson & Johnson)
Attorney Name: Keith J. Miller
Robinson Miller
Assertio Therapeutics, Inc.
Attorney Name: Keith J. Miller
Robinson Miller
JANSSEN PHARMACEUTICALS (Johnson & Johnson)
Attorney Name: Donald A. Robinson
Robinson Miller
Assertio Therapeutics, Inc.
Attorney Name: Donald A. Robinson
Robinson Miller
Defendant Attorneys
Actavis Laboratories UT
Attorney Name: Sheila Wiggins
Duane Morris LLP
Counter Defendant
5Grunenthal
Attorney Name: John F. Brenner
Troutman Pepper Locke LLP
Grunenthal
Attorney Name: Melissa A. Chuderewicz
Troutman Pepper Locke LLP
Grunenthal
Attorney Name: Ronni E. Fuchs
Troutman Pepper Locke LLP
JANSSEN PHARMACEUTICALS (Johnson & Johnson)
Attorney Name: Keith J. Miller
Robinson Miller
JANSSEN PHARMACEUTICALS (Johnson & Johnson)
Attorney Name: Donald A. Robinson
Robinson Miller
Counter Claimant
Actavis Laboratories UT
Attorney Name: Sheila Wiggins
Duane Morris LLP
Cause
35:271 Patent Infringement
Related Patents
| Doc No | Title | Issue date |
|---|---|---|
| 07994364 | Crystalline forms of (−)-(1R,2R)-3-(3-dimethylamino-1-ethyl-2-methylpropyl)-phenol hydrochloride | Aug 9, 2011 |
| 06248737 | 1-phenyl-3-dimethylaminopropane compounds with a pharmacological effects | Jun 19, 2001 |
